Healthcare news on August 21, 2026

1. 0113:30 UTC

   Coverage recordbusiness-standard.com: “MediSage Receives Asia Book of Records with Over 800, 000+ Registered Doctors”

   2 outlets · first: Business Standard Health IT

   Reports ran between 13:30 and 14:45 UTC on Aug 21.

   The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).

   Reported by Business Standard, bangladeshsun.com (Big News Network) and nepalnational.com (Big News Network).

   • Asia Book of Records
   • MediSage

2. 0216:15 UTC

   Ebola's 47.6% fatality rate and 5,290 cases

   2 outlets · first: globalissues.org

   Machine summary DR Congo's Ebola outbreak has 5,290 cases and a 47.6% fatality rate. Healthcare workers face infection and attack risks while funding runs out, according to the report.

   1. 5,290 people have been infected and 2,516 have died since the outbreak was declared on 15 May 2026, a case fatality rate of 47.6%.
   2. Half of all Ebola deaths in the outbreak occurred in just the last 20 days, according to the UN Senior Ebola Coordinator.
   3. Ebola has infected 160 healthcare workers, and 43 of those workers have died.
   4. Contact follow-up is at 82.9%; 1,152 people have recovered and nearly 840 remain isolated or hospitalized.

   Reported by globalissues.org and aa.com.tr.

   • Ebola outbreak (DRC)

3. 0312:06 UTC

   Werewolf Therapeutics to merge with Ambros in $150m deal

   2 outlets · first: za.investing.com Acquisition

   Machine summary The Werewolf-Ambros merger creates a Nasdaq-listed company focused on neridronate for CRPS-1, a pain indication affecting 65,000 newly diagnosed U.S. patients yearly. A $150 million financing funds a 270-patient pivotal Phase 3 trial.

   1. Werewolf Therapeutics shares rose 1,431.19% in pre-market trading after the merger announcement.
   2. The all-stock merger values Ambros at $500 million and Werewolf at approximately $47.5 million before the private placement.
   3. Janus Henderson Investors and RA Capital Management jointly led the oversubscribed, concurrent private placement, which amounted to $150 million.
   4. Neridronate's pivotal CRPS-RISE Phase 3 trial is planned to enroll about 270 patients with warm CRPS-1, with topline results planned for 2028.
   5. CRPS-1 affects an estimated 65,000 newly diagnosed U.S. patients per year and has no FDA-approved specific treatment.

   Reported by za.investing.com and Rttnews.

   • Janus Henderson Investors
   • Werewolf Therapeutics
   • CRPS-RISE Phase 3 trial
   • RA Capital Management
   • Ambros Therapeutics
   • Neridronate

4. 0419:15 UTC

   Dual E. coli + Salmonella Outbreak Sickens 41; Co-Infections Found

   1 outlet · first: iHeartRadio Regulation

   Machine summary Minnesota and Wisconsin officials linked 41 illnesses to alfalfa sprouts contaminated with both Salmonella and Shiga toxin-producing E. coli.

   1. 41 confirmed illnesses — 23 in Minnesota and 18 in Wisconsin — with 2 hospitalizations and more cases expected as the investigation continues.
   2. The single source yielded two pathogens: one Salmonella type and three Shiga toxin-producing E. coli (STEC) strains, with some patients co-infected by both.
   3. The sprouts affected were sold to the grocery stores Cub, Kowalski's and Jerry's, and to restaurants, under the brands Everything Sprouts and Calco.
   4. The FDA sent Everything Sprouts a warning letter in March 2025, alleging that a 2024 inspection found Produce Safety Rule violations, including roof leaks dripping onto exposed sprouts.
   5. Traceback combined patient interviews about sprout sandwiches with restaurant invoice review to identify Everything Sprouts as the common supplier.

   Reported by iHeartRadio.

   • Salmonella
   • Cub
   • Calco
   • Kowalski's
   • Shiga toxin-producing E. coli (STEC)
   • Everything Sprouts

Each summary and its key facts are a machine summary of the reports linked under it; the outlets, times and counts come from those reports' own records. How a rundown is built.